NCT00271063View on ClinicalTrials.gov

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2008

Conditions
Acute Lymphocytic Leukemia
Interventions
DRUG

Liposomal Annamycin

3-day IV infusion

Trial Locations (3)

10467

RECRUITING

Montefiore Medical Center, The Bronx

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

77030

RECRUITING

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Callisto Pharmaceuticals

INDUSTRY